id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-339737-7qdjea6f	Sbidian, E.	Hydroxychloroquine with or without azithromycin and in-hospital mortality or discharge in patients hospitalized for COVID-19 infection: a cohort study of 4,642 in-patients in France	2020-06-19		.txt	text/plain	6035	306	45	-Using a large non-selected population of inpatients hospitalized for COVID-19 infection in 39 hospitals in France and robust methodological approaches, we found no evidence for efficacy of HCQ on 28-day mortality -Our results suggest an excess risk of mortality in patients treated by a combination of HCQ and AZI, but not with HCQ alone -Significantly higher rates of discharge home were observed in patients treated by HCQ, a novel finding warranting further confirmation in replicative studies . Results from competing risks multivariable analyses for 28-day mortality and hospital discharge are displayed in Table 3 , showing both raw unadjusted estimates for the average treatment effect of 'HCQ alone 'or 'HCQ plus AZI', and AIPTW results from double robust estimation accounting for confounders for the outcome and the treatment allocation.	./cache/cord-339737-7qdjea6f.txt	./txt/cord-339737-7qdjea6f.txt